The global lateral flow assay test market is expected to witness major growth in the forecast period owing to increased incidences of chronic illnesses and rise in the geriatric population, according to a report by Persistence Market Research.
Key findings about the global lateral flow assay test market are as follows:
1. The market is projected to report strong growth owing to high prevalence of infectious and communicable diseases.
2. Rise in geriatric population, increased use in clinical laboratories, rise in chronic illnesses, and innovation in technology driving the global market.
3. Growing regulation, inconsistent results restraining the market.
4. Global players concentrating on new technologies to capture major market share.
5. Big players merging with small lab chains to form large networks and increase revenue generation.
Thinking about report: Please observe the beneath the hyperlinks to satisfy your necessities; Request for the Report sample : http://www.persistencemarketresearch.com/samples/11236
6. In terms of application, clinical laboratories segment is expected to grow the fastest owing to high prevalence of chronic and acute diseases.
7. In terms of end user, the global market is segmented into clinics, hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, and home care.
8. North America and Europe are key markets owing to evolved health care system and high demand for decentralized laboratory testing.
9. Asia Pacific is projected to register strong growth owing to improved infrastructure, affordable pricing, and rising government initiatives.
10. F. Hoffmann-La Roche AG, Alere Inc., and Abbott Laboratories are the top three companies in the global lateral flow assay test market.
For more information on the global lateral flow assay test market, follow the link: http://www.persistencemarketresearch.com/toc/11236
Key players in the global lateral flow assay test market include Thermo Fisher Scientific, Inc., Johnson & Johnson, Abbott Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, and Alere, Inc.